Table 1.

Characterization of DCT-loaded PS-PDLLA copolymer-based NPs

Composition	Mean diameter (nm)	Polydispersity index	Zeta potential (mV)	EE (%)
PS-PDLLA/DCT NP (PS-PDLLA:DCT =5:1)	224.63±7.66	0.08±0.01	−13.52±0.73	83.51±0.56
PS-PDLLA/DCT NP (PS-PDLLA:DCT =10:1)	242.13±3.79	0.09±0.01	−9.30±1.47	85.25±6.11

Notes: Data are presented as means ± SD (n=3); $\text{EE}(\%)=\frac{\text{actual amount of drug in NPs}}{\text{input amount of drug in NPs}}\times 100$.

Abbreviations: DCT, docetaxel; EE, encapsulation efficiency; NP, nanoparticle; PS-PDLLA, poly(styrene)-b-poly(DL-lactide); SD, standard deviation.